Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Giaccone

Showing results (311-320 of 359) with videos related to

Pageof 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative GroupP E Postmus, H Haaxma-Reiche, E F Smit, et al.
Journal of the National Cancer Institute|August 16, 1995
Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinomaM A Izquierdo, A G van der Zee, J B Vermorken, et al.
Neurology|September 15, 2004
A family with Alzheimer disease and strokes associated with A713T mutation of the APP geneG Rossi, G Giaccone, R Maletta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Bepridil in combination with anthracyclines to reverse anthracycline resistance in cancer patientsC K van Kalken, J J van der Hoeven, J de Jong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative groupC Manegold, P Drings, A Pawinski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III studyV C Tjan-Heijnen, P E Postmus, A Ardizzoni, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumoursC J van Moorsel, H M Pinedo, K Smid, et al.
Anti-Cancer Drugs|December 29, 2000
Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol) and carboplatin in non-small cell lung cancer patientsJ Meerum Terwogt, O van Tellingen, V R Nannan Panday, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancerR M Apolinario, P van der Valk, J S de Jong, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2018
Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancerA A van Zweeden, C J van Groeningen, R J Honeywell, et al.
Pageof 36

Showing results (311-320 of 359) with videos related to

Sort By:
Pageof 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative GroupP E Postmus, H Haaxma-Reiche, E F Smit, et al.
Journal of the National Cancer Institute|August 16, 1995
Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinomaM A Izquierdo, A G van der Zee, J B Vermorken, et al.
Neurology|September 15, 2004
A family with Alzheimer disease and strokes associated with A713T mutation of the APP geneG Rossi, G Giaccone, R Maletta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Bepridil in combination with anthracyclines to reverse anthracycline resistance in cancer patientsC K van Kalken, J J van der Hoeven, J de Jong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1996
Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative groupC Manegold, P Drings, A Pawinski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III studyV C Tjan-Heijnen, P E Postmus, A Ardizzoni, et al.
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumoursC J van Moorsel, H M Pinedo, K Smid, et al.
Anti-Cancer Drugs|December 29, 2000
Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol) and carboplatin in non-small cell lung cancer patientsJ Meerum Terwogt, O van Tellingen, V R Nannan Panday, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancerR M Apolinario, P van der Valk, J S de Jong, et al.
Cancer Chemotherapy and Pharmacology|April 27, 2018
Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancerA A van Zweeden, C J van Groeningen, R J Honeywell, et al.
Pageof 36